Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity

Jianbo He(Guangzhou University of Chinese Medicine), Jiake Xu(Guangxi Medical University)
Frontiers in Pharmacology
September 23, 2021
Cited by 26


Related Papers